Big Weeks Ahead for MedTech and Life Science Stocks …Update-4
Hot fun in the summertime! Will try to post a new article on Healthcare and Biotech tomorrow August 7. Update-4 Aug 3...Large cap biopharmas favored as spec stocks fade with XBI at $81 handle lacking momentum, near low for 30 days. Earnings looking good for large cap top picks REGN and...
Rayno BioBeat: Playbook Revisited as UNH Beat Could Help Sagging Healthcare Stocks…Update-2 rotation pivot
Update-2 Jy 22 Catch-up Rally last week continues in MedTech and Diagnostics: ABT our top pick up 5.89% to $114.29, DHR up 6.38% to $255.88,IHI up 1.32% to $57.59,TMO up 6.89% to $562. New Pick Becton Dickinson (BDX) up 2.1% to $264.84. Earnings coming next week for many MedTech stocks....
Biotech Blues: Stay Balanced Through July Earnings Season …Update-4 …JY 12: Biotech rally time!
Update-4 JY 12...Some biotech strength in usual suspects but exciting news drives smaller more speculative stocks. Recursion pharmaceuticals (RXRX) up 78% on $50M Nvidia drug discovery deal. As rumored AI meets biotech.Trading rally for sure as more AI plays likely. SMID favorites...
Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead …Update-2
Update-2 Flashback from 1/19 and 2018 Performance. Big winner in 2018 was MRK up 33% to $76.41 but 2018 was a bad year with the XBI down 15% to $71.75. But Regeneron was a bargain on 1/19 at $373. Update-1 6/27...A bad day for Biotech but a nice rally day for Tech Most biotech shares were weak...
Biotech and Healthcare Stocks Lagging
Healthcare Stocks Lag but Trading Action is Picking up in Biotech Large Cap Biopharma are core holdings: ABBV, LLY, MRK, REGN, VRTX etc. Healthcare is a laggard with XLV down YTD but UNH is still a core position. Lack of Momentum in SMID caps-XBI is still the key indicator. Not much happened...